Addex Therapeutics (ADXN) Assets Average (2022 - 2025)
Historic Assets Average for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $9.7 million.
- Addex Therapeutics' Assets Average fell 3340.96% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 3340.96%. This contributed to the annual value of $8.7 million for FY2024, which is 2495.31% up from last year.
- Latest data reveals that Addex Therapeutics reported Assets Average of $9.7 million as of Q3 2025, which was down 3340.96% from $10.4 million recorded in Q2 2025.
- Addex Therapeutics' Assets Average's 5-year high stood at $15.5 million during Q2 2022, with a 5-year trough of $4.5 million in Q1 2024.
- Its 4-year average for Assets Average is $10.2 million, with a median of $10.1 million in 2025.
- In the last 5 years, Addex Therapeutics' Assets Average plummeted by 4506.54% in 2024 and then skyrocketed by 15111.48% in 2025.
- Addex Therapeutics' Assets Average (Quarter) stood at $10.6 million in 2022, then crashed by 42.73% to $6.1 million in 2023, then soared by 115.35% to $13.1 million in 2024, then dropped by 25.9% to $9.7 million in 2025.
- Its last three reported values are $9.7 million in Q3 2025, $10.4 million for Q2 2025, and $11.4 million during Q1 2025.